What are the recent financial highlights of CAPLIN POINT LAB LTD.?

CAPLIN POINT LAB LTD. recently reported a total revenue of ₹1,890.25 Cr and a net profit margin of 27.26%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of CAPLIN POINT LAB LTD.?

CAPLIN POINT LAB LTD. offers a dividend yield of 0.26%, with a dividend rate of ₹5.0 per share.

What are the key financial metrics of CAPLIN POINT LAB LTD.?

Key financial metrics include a trailing P/E ratio of 26.971516, forward P/E of 22.812424, book value of ₹324.909, price-to-book ratio of 5.595875, and a market capitalization of ₹138.26 billion.

What does CAPLIN POINT LAB LTD. do?

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Caplipoint

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Caplipoint

Latest updates related to Caplipoint

Sr No.	Title	Sentiment
1	NSE CAPLIPOINT & AUROPHARMA – Trading Insight and Update Moneymunch	🔄
2	The recent pullback must have dismayed Caplin Point Laboratories Limited (NSE:CAPLIPOINT) insiders who own 69% of the company Simply Wall St	🔄
3	Is Weakness In Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St	🔄
4	Some Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Shareholders Look For Exit As Shares Take 27% Pounding Simply Wall St	🔄
5	Caplin Point Laboratories (NSE:CAPLIPOINT) sheds 6.5% this week, as yearly returns fall more in line with earnings growth Simply Wall St	🔄
6	NSE CAPLIPOINT & AUROPHARMA – Trading Insight and Update Moneymunch	🔄
7	Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St	🔄
8	CAPLIPOINT Stock Price and Chart — NSE:CAPLIPOINT TradingView	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

VISAKAIND AVANTIFEED SESHAPAPER CENTRUM BEML ZEAL JKPAPER THEMISMED VERITAAS POONAWALLA